Costs of Hospital Events in Patients with Metastatic Colorectal Cancer

被引:0
|
作者
Overbeek, Jetty A. [1 ]
Zhao, Zhongyun [2 ]
van Herk-Sukel, Myrthe P. P. [1 ]
Barber, Beth L. [2 ]
Gao, Sue [2 ]
Herings, Ron M. C. [1 ,3 ]
机构
[1] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Erasmus MC, Rotterdam, Netherlands
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
635
引用
收藏
页码:S277 / S277
页数:1
相关论文
共 50 条
  • [21] Treatment pathways and associated costs of metastatic colorectal cancer in Greece
    Sougklakos, Ioannis
    Athanasiadis, Elias
    Boukovinas, Ioannis
    Karamouzis, Michalis
    Koutras, Aggelos
    Papakotoulas, Paulos
    Latsou, Dimitra
    Hatzikou, Magda
    Stamuli, Eugena
    Balasopoulos, Athanasios
    Sideris, Aggelos
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2022, 20 (01)
  • [22] Variation in hospital treatment patterns for metastatic colorectal cancer
    Krell, Robert W.
    Regenbogen, Scott E.
    Wong, Sandra L.
    CANCER, 2015, 121 (11) : 1755 - 1761
  • [23] Hospital treatment patterns and survival for metastatic colorectal cancer
    Krell, Robert Wallace
    Regenbogen, Scott E.
    Banerjee, Mousumi
    Wong, Sandra L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] COMORBIDITIES IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Fu, A. Z.
    Zhao, Z.
    Wang, P. F.
    Barber, B.
    Liu, G.
    VALUE IN HEALTH, 2009, 12 (07) : A257 - A257
  • [25] Avelumab in Patients With Metastatic Colorectal Cancer
    Redman, Jason M.
    Coyne, Geraldine O'Sullivan
    Reed, Clay T.
    Madan, Ravi A.
    Strauss, Julius
    Steinberg, Seth J.
    Marte, Jennifer
    Cordes, Lisa
    Heery, Christopher
    Gulley, James L.
    ONCOLOGIST, 2023, 28 (09): : 823 - E804
  • [26] Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA
    Grivas, Petros
    DerSarkissian, Maral
    Shenolikar, Rahul
    Laliberte, Francois
    Doleh, Yunes
    Duh, Mei Sheng
    FUTURE ONCOLOGY, 2019, 15 (33) : 3809 - 3818
  • [27] Treatment costs of skeletal-related events (SRE) in patients with metastatic breast or prostate cancer
    Felix, J.
    Andreozzi, V.
    Soares, M.
    Passos-Coelho, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 172 - 173
  • [28] Utilization and costs of supportive medications among patients with metastatic breast (mBC) or colorectal cancer (mCRC).
    Dugan, U
    Baran, RW
    Barron, J
    Law, AW
    Waugh, WJ
    Grochulski, WD
    Cummins, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 543S - 543S
  • [29] Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital
    Dane, Faysal
    Yumuk, Fulden
    Gumus, Mahmut
    Iyikesici, Salih
    Tufan, A.
    Basaran, Gul
    Cabuk, Devrim
    Teomete, Mehmet
    Turhal, Nazim S.
    ANNALS OF ONCOLOGY, 2006, 17 : 129 - 129
  • [30] RETROSPECTIVE REVIEW OF PATIENTS MANAGED WITH CHEMOTHERAPY FOR METASTATIC COLORECTAL CANCER AT THE PRINCESS ALEXANDRA HOSPITAL
    Ryan, C.
    Atkinson, V.
    Klein, K.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 56 - 56